Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Danaher Corp. (DHR)
NYSE:DHR
Danaher (DHR) Stock Price & Analysis
2,471 Followers
DHR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$181.70 - $258.72
Previous Close$235.51
Volume2.82M
Average Volume (3M)2.68M
Market Cap
$174.41B
Enterprise Value$192.81B
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$18.40B
Price to Earnings (P/E)36.9
Beta1.03
Next Earnings
Apr 23, 2024EPS Estimate
$1.72Last Dividend Ex-Date
Mar 27, 2024Dividend Yield0.45%
Share Statistics
EPS (TTM)6.38
Shares Outstanding739,701,725
10 Day Avg. Volume2,665,979
30 Day Avg. Volume2,677,096
Standard Deviation0.07
R-Squared0.39
Alpha0.00573
Financial Highlights & Ratios
Price to Book (P/B)-19.64
Price to Sales (P/S)7.29
Price to Cash Flow (P/CF)26.90
P/FCF Ratio33.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.07
Enterprise Value/Gross Profit13.74
Enterprise Value/Ebitda25.69
Forecast
1Y Price Target
$271.43Price Target Upside14.97% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
Danaher News
PremiumPress Releases
Danaher Reports First Quarter 2024 Results
Bulls Say, Bears Say
Bulls Say
Analyst's ConfidenceWith a Buy rating and a target price increase to $280, the analyst's outlook reflects confidence in DHR's strategic management and its conservative yet positive revenue and margin guidance.
Financial PerformanceDHR's management is recognized for generating operating leverage in bioprocessing, leading to high EBITA margins and incremental sales growth, indicating a solid financial foundation.
Revenue Growth PotentialAnalyst recommends DHR as the leader in the bioprocess tools market with a diversified portfolio in Life Science Tools and Diagnostics, poised for high-single-digit growth exiting 2024.
Bears Say
Bioprocessing SectorVisibility in Bioprocessing remains limited with continued destocking in the first half of the year.
GuidanceInitial 2024 revenue guidance came in slightly below expectations.
Market DemandOn China, demand remains weak as customers continue to conserve capital.
---
Ownership Overview
9.18% Insiders
27.54% Mutual Funds
17.73% Other Institutional Investors
45.54% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
DHR FAQ
What was Danaher Corp.’s price range in the past 12 months?
Danaher Corp. lowest stock price was $181.70 and its highest was $258.72 in the past 12 months.
What is Danaher Corp.’s market cap?
Currently, no data Available
When is Danaher Corp.’s upcoming earnings report date?
Danaher Corp.’s upcoming earnings report date is Apr 23, 2024 which is today.
How were Danaher Corp.’s earnings last quarter?
Danaher Corp. released its earnings results on Jan 30, 2024. The company reported $2.09 earnings per share for the quarter, beating the consensus estimate of $1.913 by $0.177.
Is Danaher Corp. overvalued?
According to Wall Street analysts Danaher Corp.’s price is currently Undervalued.
Does Danaher Corp. pay dividends?
Danaher Corp. pays a Quarterly dividend of $0.27 which represents an annual dividend yield of 0.45%. See more information on Danaher Corp. dividends here
What is Danaher Corp.’s EPS estimate?
Danaher Corp.’s EPS estimate is $1.72.
How many shares outstanding does Danaher Corp. have?
Danaher Corp. has 740,544,200 shares outstanding.
What happened to Danaher Corp.’s price movement after its last earnings report?
Danaher Corp. reported an EPS of $2.09 in its last earnings report, beating expectations of $1.913. Following the earnings report the stock price went up 4.707%.
Which hedge fund is a major shareholder of Danaher Corp.?
Among the largest hedge funds holding Danaher Corp.’s share is Fisher Asset Management LLC. It holds Danaher Corp.’s shares valued at 978M.
---
Danaher Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$271.43 (14.97% Upside)
$271.43 (14.97% Upside)
Blogger Sentiment
Bullish
DHR Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 87.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $8.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 5.0%
Last 30 Days ▼ 5.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
4.76%
12-Months-Change
Fundamentals
Return on Equity
9.28%
Trailing 12-Months
Asset Growth
0.16%
Trailing 12-Months
Company Description
Danaher Corp.
Founded in 1969 and headquartered in Washington, DC, Danaher Corp. engages in manufacturing, designing and marketing of professional, medical, industrial and commercial products and services. The company operates through three segments, including Life Sciences, Diagnostics, and Environmental & Applied Solutions.
---
DHR Company Deck
---
DHR Earnings Call
Q4 2024
0:00 / 0:00
---
DHR Revenue Breakdown
40.09% Diagnostics
30.02% Biotechnology
29.89% Life Sciences
---
DHR Stock 12 Months Forecast
Average Price Target
$271.43
▲(14.97% Upside)
Technical Analysis
Best Analysts Covering DHR
1 Year
1 Year Success Rate
23/29 ratings generated profit
1 Year Average Return
+12.17%
reiterated a buy rating 3 months ago
Copying Brandon Couillard's trades and holding each position for 1 Year would result in 79.31% of your transactions generating a profit, with an average return of +12.17% per trade.
---